MENU
+Compare
USAQ
Stock ticker: OTC
AS OF
Sep 2 closing price
Price
$0.19
Change
-$0.00 (-0.00%)
Capitalization
2.02M

USAQ stock forecast, quote, news & analysis

QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians... Show more

USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for USAQ with price predictions
Sep 04, 2025

USAQ's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for USAQ turned positive on August 29, 2025. Looking at past instances where USAQ's MACD turned positive, the stock continued to rise in of 69 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

USAQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on September 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on USAQ as a result. In of 138 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

USAQ moved below its 50-day moving average on August 08, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for USAQ crossed bearishly below the 50-day moving average on August 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for USAQ moved below the 200-day moving average on August 18, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

The Aroon Indicator for USAQ entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (60.235). P/E Ratio (0.000) is within average values for comparable stocks, (38.150). USAQ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.671). USAQ has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.804) is also within normal values, averaging (80.766).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. USAQ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USAQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.65B. The market cap for tickers in the group ranges from 1.86K to 231.38B. ABT holds the highest valuation in this group at 231.38B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -0%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 25%. VMTHF experienced the highest price growth at 107%, while AEMD experienced the biggest fall at -64%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 97%. For the same stocks of the Industry, the average monthly volume growth was 84% and the average quarterly volume growth was 40%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 77
Price Growth Rating: 62
SMR Rating: 88
Profit Risk Rating: 92
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
901 Northpoint Parkway
Phone
+1 929 379-6503
Employees
4
Web
https://www.qhslab.com